Clinical impact of PTEN genomic deletions and TMPRSS2-ERG gene fusions in prostate cancer
Maisa Yoshimoto(University of Alberta), Jeremy A. Squire(Universidade de São Paulo), Paula Marrano, Isabela Werneck da Cunha(AC Camargo Hospital), Fernando Augusto Soares(University of Connecticut), F.P. Fonseca(AC Camargo Hospital), Renata A. Coudry(AC Camargo Hospital), Bayani Jane(Instituto do Câncer do Estado de São Paulo), Olga Ludkovski
Cancer Research
May 1, 2007
Cited by 0
Related Papers
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
|British Journal of Cancer|2007|294
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
|Modern Pathology|2008|278
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
|Journal of Clinical Oncology|2011|256